サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1120813

世界のインクレチン系薬剤市場：考察と予測 (2028年まで)

Global Incretin-Based Drugs Market Insights, Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 121 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.36円
世界のインクレチン系薬剤市場：考察と予測 (2028年まで)
出版日: 2022年08月31日
発行: QYResearch
ページ情報: 英文 121 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、インクレチン系薬剤 (Incretin-Based Drugs) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • インクレチン系薬剤の製品概要
  • 市場：タイプ別
    • 世界のインクレチン系薬剤の市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
    • Glucagon-like peptide-1 receptor (GLP-1) agonists
    • Dipeptidyl Peptidase-4 (DPP-4) inhibitors
  • 市場：アプリケーション別
    • 世界のインクレチン系薬剤の市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
    • Oral Drugs
    • Injectable Drugs
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界のインクレチン系薬剤の販売 推定および予測 2017-2028
  • 世界のインクレチン系薬剤の収益 推定および予測 2017-2028
  • 世界のインクレチン系薬剤の収益：地域別: 2017 VS 2021 VS 2028
  • 世界のインクレチン系薬剤の販売：地域別
    • 世界のインクレチン系薬剤の販売：地域別 (2017-2022)
    • 世界の販売 インクレチン系薬剤 ：地域別 (2023-2028)
  • 世界のインクレチン系薬剤の収益：地域別
    • 世界のインクレチン系薬剤の収益：地域別 (2017-2022)
    • 世界のインクレチン系薬剤の収益：地域別 (2023-2028)
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第3章 競合：メーカー別

  • 世界のインクレチン系薬剤の販売：メーカー別
    • 世界のインクレチン系薬剤の上位メーカー：販売別 (2017-2022)
    • 世界のインクレチン系薬剤の販売市場シェア：メーカー別 (2017-2022)
    • 世界の上位10・上位5メーカー： インクレチン系薬剤2021
  • 世界のインクレチン系薬剤の収益：メーカー別
    • 世界のインクレチン系薬剤の収益：メーカー別 (2017-2022)
    • 世界のインクレチン系薬剤の収益市場シェア：メーカー別 (2017-2022)
    • 世界の上位10・上位5企業： インクレチン系薬剤の収益 2021
  • 世界のインクレチン系薬剤の販売価格：メーカー別 (2017-2022)
  • 競合情勢の分析
    • メーカーの市場集中度 (CR5 and HHI)
    • 世界のインクレチン系薬剤の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
    • 世界のインクレチン系薬剤のメーカーの地理的分布
  • M&A, 拡張計画

第4章 市場規模：タイプ別

  • 世界のインクレチン系薬剤の販売：タイプ別
    • 世界のインクレチン系薬剤の販売実績：タイプ別 (2017-2022)
    • 世界のインクレチン系薬剤の販売予測：タイプ別 (2023-2028)
    • 世界のインクレチン系薬剤の販売市場シェア：タイプ別 (2017-2028)
  • 世界のインクレチン系薬剤の収益：タイプ別
    • 世界のインクレチン系薬剤の収益実績：タイプ別 (2017-2022)
    • 世界のインクレチン系薬剤の収益予測：タイプ別 (2023-2028)
    • 世界のインクレチン系薬剤の収益市場シェア：タイプ別 (2017-2028)
  • 世界のインクレチン系薬剤の価格：タイプ別
    • 世界のインクレチン系薬剤の価格：タイプ別 (2017-2022)
    • 世界のインクレチン系薬剤の価格予測：タイプ別 (2023-2028)

第5章 市場規模：アプリケーション別

  • 世界のインクレチン系薬剤の販売：アプリケーション別
    • 世界のインクレチン系薬剤の販売実績：アプリケーション別 (2017-2022)
    • 世界のインクレチン系薬剤の販売予測：アプリケーション別 (2023-2028)
    • 世界のインクレチン系薬剤の販売市場シェア：アプリケーション別 (2017-2028)
  • 世界のインクレチン系薬剤の収益：アプリケーション別
    • 世界のインクレチン系薬剤の収益実績：アプリケーション別 (2017-2022)
    • 世界のインクレチン系薬剤の収益予測：アプリケーション別 (2023-2028)
    • 世界のインクレチン系薬剤の収益市場シェア：アプリケーション別 (2017-2028)
  • 世界のインクレチン系薬剤の価格：アプリケーション別
    • 世界のインクレチン系薬剤の価格：アプリケーション別 (2017-2022)
    • 世界のインクレチン系薬剤の価格予測：アプリケーション別 (2023-2028)

第6章 北米

  • 北米のインクレチン系薬剤 市場規模：タイプ別
    • 北米のインクレチン系薬剤の販売：タイプ別 (2017-2028)
    • 北米のインクレチン系薬剤の収益：タイプ別 (2017-2028)
  • 北米のインクレチン系薬剤 市場規模：アプリケーション別
    • 北米のインクレチン系薬剤の販売：アプリケーション別 (2017-2028)
    • 北米のインクレチン系薬剤の収益：アプリケーション別 (2017-2028)
  • 北米のインクレチン系薬剤 市場規模：国別
    • 北米のインクレチン系薬剤の販売：国別 (2017-2028)
    • 北米のインクレチン系薬剤の収益：国別 (2017-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州のインクレチン系薬剤 市場規模：タイプ別
    • 欧州のインクレチン系薬剤の販売：タイプ別 (2017-2028)
    • 欧州のインクレチン系薬剤の収益：タイプ別 (2017-2028)
  • 欧州のインクレチン系薬剤 市場規模：アプリケーション別
    • 欧州のインクレチン系薬剤の販売：アプリケーション別 (2017-2028)
    • 欧州のインクレチン系薬剤の収益：アプリケーション別 (2017-2028)
  • 欧州のインクレチン系薬剤 市場規模：国別
    • 欧州のインクレチン系薬剤の販売：国別 (2017-2028)
    • 欧州のインクレチン系薬剤の収益：国別 (2017-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 アジア太平洋

  • アジア太平洋のインクレチン系薬剤 市場規模：タイプ別
    • アジア太平洋のインクレチン系薬剤の販売：タイプ別 (2017-2028)
    • アジア太平洋のインクレチン系薬剤の収益：タイプ別 (2017-2028)
  • アジア太平洋のインクレチン系薬剤 市場規模：アプリケーション別
    • アジア太平洋のインクレチン系薬剤の販売：アプリケーション別 (2017-2028)
    • アジア太平洋のインクレチン系薬剤の収益：アプリケーション別 (2017-2028)
  • アジア太平洋のインクレチン系薬剤 市場規模：地域別
    • アジア太平洋のインクレチン系薬剤の販売：地域別 (2017-2028)
    • アジア太平洋のインクレチン系薬剤の収益：地域別 (2017-2028)
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • 台湾
    • インドネシア
    • タイ
    • マレーシア
    • フィリピン

第9章 ラテンアメリカ

  • ラテンアメリカのインクレチン系薬剤 市場規模：タイプ別
    • ラテンアメリカのインクレチン系薬剤の販売：タイプ別 (2017-2028)
    • ラテンアメリカのインクレチン系薬剤の収益：タイプ別 (2017-2028)
  • ラテンアメリカのインクレチン系薬剤 市場規模：アプリケーション別
    • ラテンアメリカのインクレチン系薬剤の販売：アプリケーション別 (2017-2028)
    • ラテンアメリカのインクレチン系薬剤の収益：アプリケーション別 (2017-2028)
  • ラテンアメリカのインクレチン系薬剤 市場規模：国別
    • ラテンアメリカのインクレチン系薬剤の販売：国別 (2017-2028)
    • ラテンアメリカのインクレチン系薬剤の収益：国別 (2017-2028)
    • メキシコ
    • ブラジル
    • アルゼンチン

第10章 中東・アフリカ

  • 中東・アフリカのインクレチン系薬剤 市場規模：タイプ別
    • 中東・アフリカのインクレチン系薬剤の販売：タイプ別 (2017-2028)
    • 中東・アフリカのインクレチン系薬剤の収益：タイプ別 (2017-2028)
  • 中東・アフリカのインクレチン系薬剤 市場規模：アプリケーション別
    • 中東・アフリカのインクレチン系薬剤の販売：アプリケーション別 (2017-2028)
    • 中東・アフリカのインクレチン系薬剤の収益：アプリケーション別 (2017-2028)
  • 中東・アフリカのインクレチン系薬剤 市場規模：国別
    • 中東・アフリカのインクレチン系薬剤の販売：国別 (2017-2028)
    • 中東・アフリカのインクレチン系薬剤の収益：国別 (2017-2028)
    • トルコ
    • サウジアラビア

第11章 企業プロファイル

  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck & Co
  • AstraZeneca
  • Novartis
  • Eli Lilly and Company
  • Boehringer Ingelheim
  • Takeda Pharmaceutical Company
  • Sanofi

第12章 業界チェーンと販売チャネルの分析

  • インクレチン系薬剤 業界チェーン分析
  • インクレチン系薬剤 主要原材料分析
    • 主要原材料分析
    • 原材料の主要サプライヤー
  • インクレチン系薬剤 生産形態とプロセス
  • インクレチン系薬剤 販売およびマーケティング
    • インクレチン系薬剤 販売チャネル
    • インクレチン系薬剤 卸業者
  • インクレチン系薬剤 顧客

第13章 市場の促進要因, 機会, 課題とリスク要因の分析

  • インクレチン系薬剤 業界動向
  • インクレチン系薬剤 市場の促進要因
  • インクレチン系薬剤 市場の課題
  • インクレチン系薬剤 市場の抑制要因

第14章 世界のインクレチン系薬剤の主な市場調査結果

第15章 付録

図表
  • Table 1. Global Incretin-Based Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 2. Major Manufacturers of Glucagon-like peptide-1 receptor (GLP-1) agonists
  • Table 3. Major Manufacturers of Dipeptidyl Peptidase-4 (DPP-4) inhibitors
  • Table 4. Global Incretin-Based Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 5. Global Incretin-Based Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 6. Global Incretin-Based Drugs Sales by Region (2017-2022) & (K Units)
  • Table 7. Global Incretin-Based Drugs Sales Market Share by Region (2017-2022)
  • Table 8. Global Incretin-Based Drugs Sales by Region (2023-2028) & (K Units)
  • Table 9. Global Incretin-Based Drugs Sales Market Share by Region (2023-2028)
  • Table 10. Global Incretin-Based Drugs Revenue by Region (2017-2022) & (US$ Million)
  • Table 11. Global Incretin-Based Drugs Revenue Market Share by Region (2017-2022)
  • Table 12. Global Incretin-Based Drugs Revenue by Region (2023-2028) & (US$ Million)
  • Table 13. Global Incretin-Based Drugs Revenue Market Share by Region (2023-2028)
  • Table 14. Global Incretin-Based Drugs Sales by Manufacturers (2017-2022) & (K Units)
  • Table 15. Global Incretin-Based Drugs Sales Share by Manufacturers (2017-2022)
  • Table 16. Global Incretin-Based Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
  • Table 17. Global Incretin-Based Drugs Revenue Share by Manufacturers (2017-2022)
  • Table 18. Incretin-Based Drugs Price by Manufacturers (2017-2022) &(US$/Unit)
  • Table 19. Global Incretin-Based Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 20. Global Incretin-Based Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Incretin-Based Drugs as of 2021)
  • Table 21. Incretin-Based Drugs Manufacturing Base Distribution and Headquarters
  • Table 22. Manufacturers Incretin-Based Drugs Product Offered
  • Table 23. Date of Manufacturers Enter into Incretin-Based Drugs Market
  • Table 24. Mergers & Acquisitions, Expansion Plans
  • Table 25. Global Incretin-Based Drugs Sales by Type (2017-2022) & (K Units)
  • Table 26. Global Incretin-Based Drugs Sales by Type (2023-2028) & (K Units)
  • Table 27. Global Incretin-Based Drugs Sales Share by Type (2017-2022)
  • Table 28. Global Incretin-Based Drugs Sales Share by Type (2023-2028)
  • Table 29. Global Incretin-Based Drugs Revenue by Type (2017-2022) & (US$ Million)
  • Table 30. Global Incretin-Based Drugs Revenue by Type (2023-2028) & (US$ Million)
  • Table 31. Global Incretin-Based Drugs Revenue Share by Type (2017-2022)
  • Table 32. Global Incretin-Based Drugs Revenue Share by Type (2023-2028)
  • Table 33. Incretin-Based Drugs Price by Type (2017-2022) & (US$/Unit)
  • Table 34. Global Incretin-Based Drugs Price Forecast by Type (2023-2028) & (US$/Unit)
  • Table 35. Global Incretin-Based Drugs Sales by Application (2017-2022) & (K Units)
  • Table 36. Global Incretin-Based Drugs Sales by Application (2023-2028) & (K Units)
  • Table 37. Global Incretin-Based Drugs Sales Share by Application (2017-2022)
  • Table 38. Global Incretin-Based Drugs Sales Share by Application (2023-2028)
  • Table 39. Global Incretin-Based Drugs Revenue by Application (2017-2022) & (US$ Million)
  • Table 40. Global Incretin-Based Drugs Revenue by Application (2023-2028) & (US$ Million)
  • Table 41. Global Incretin-Based Drugs Revenue Share by Application (2017-2022)
  • Table 42. Global Incretin-Based Drugs Revenue Share by Application (2023-2028)
  • Table 43. Incretin-Based Drugs Price by Application (2017-2022) & (US$/Unit)
  • Table 44. Global Incretin-Based Drugs Price Forecast by Application (2023-2028) & (US$/Unit)
  • Table 45. North America Incretin-Based Drugs Sales by Type (2017-2022) & (K Units)
  • Table 46. North America Incretin-Based Drugs Sales by Type (2023-2028) & (K Units)
  • Table 47. North America Incretin-Based Drugs Revenue by Type (2017-2022) & (US$ Million)
  • Table 48. North America Incretin-Based Drugs Revenue by Type (2023-2028) & (US$ Million)
  • Table 49. North America Incretin-Based Drugs Sales by Application (2017-2022) & (K Units)
  • Table 50. North America Incretin-Based Drugs Sales by Application (2023-2028) & (K Units)
  • Table 51. North America Incretin-Based Drugs Revenue by Application (2017-2022) & (US$ Million)
  • Table 52. North America Incretin-Based Drugs Revenue by Application (2023-2028) & (US$ Million)
  • Table 53. North America Incretin-Based Drugs Sales by Country (2017-2022) & (K Units)
  • Table 54. North America Incretin-Based Drugs Sales by Country (2023-2028) & (K Units)
  • Table 55. North America Incretin-Based Drugs Revenue by Country (2017-2022) & (US$ Million)
  • Table 56. North America Incretin-Based Drugs Revenue by Country (2023-2028) & (US$ Million)
  • Table 57. Europe Incretin-Based Drugs Sales by Type (2017-2022) & (K Units)
  • Table 58. Europe Incretin-Based Drugs Sales by Type (2023-2028) & (K Units)
  • Table 59. Europe Incretin-Based Drugs Revenue by Type (2017-2022) & (US$ Million)
  • Table 60. Europe Incretin-Based Drugs Revenue by Type (2023-2028) & (US$ Million)
  • Table 61. Europe Incretin-Based Drugs Sales by Application (2017-2022) & (K Units)
  • Table 62. Europe Incretin-Based Drugs Sales by Application (2023-2028) & (K Units)
  • Table 63. Europe Incretin-Based Drugs Revenue by Application (2017-2022) & (US$ Million)
  • Table 64. Europe Incretin-Based Drugs Revenue by Application (2023-2028) & (US$ Million)
  • Table 65. Europe Incretin-Based Drugs Sales by Country (2017-2022) & (K Units)
  • Table 66. Europe Incretin-Based Drugs Sales by Country (2023-2028) & (K Units)
  • Table 67. Europe Incretin-Based Drugs Revenue by Country (2017-2022) & (US$ Million)
  • Table 68. Europe Incretin-Based Drugs Revenue by Country (2023-2028) & (US$ Million)
  • Table 69. Asia Pacific Incretin-Based Drugs Sales by Type (2017-2022) & (K Units)
  • Table 70. Asia Pacific Incretin-Based Drugs Sales by Type (2023-2028) & (K Units)
  • Table 71. Asia Pacific Incretin-Based Drugs Revenue by Type (2017-2022) & (US$ Million)
  • Table 72. Asia Pacific Incretin-Based Drugs Revenue by Type (2023-2028) & (US$ Million)
  • Table 73. Asia Pacific Incretin-Based Drugs Sales by Application (2017-2022) & (K Units)
  • Table 74. Asia Pacific Incretin-Based Drugs Sales by Application (2023-2028) & (K Units)
  • Table 75. Asia Pacific Incretin-Based Drugs Revenue by Application (2017-2022) & (US$ Million)
  • Table 76. Asia Pacific Incretin-Based Drugs Revenue by Application (2023-2028) & (US$ Million)
  • Table 77. Asia Pacific Incretin-Based Drugs Sales by Region (2017-2022) & (K Units)
  • Table 78. Asia Pacific Incretin-Based Drugs Sales by Region (2023-2028) & (K Units)
  • Table 79. Asia Pacific Incretin-Based Drugs Revenue by Region (2017-2022) & (US$ Million)
  • Table 80. Asia Pacific Incretin-Based Drugs Revenue by Region (2023-2028) & (US$ Million)
  • Table 81. Latin America Incretin-Based Drugs Sales by Type (2017-2022) & (K Units)
  • Table 82. Latin America Incretin-Based Drugs Sales by Type (2023-2028) & (K Units)
  • Table 83. Latin America Incretin-Based Drugs Revenue by Type (2017-2022) & (US$ Million)
  • Table 84. Latin America Incretin-Based Drugs Revenue by Type (2023-2028) & (US$ Million)
  • Table 85. Latin America Incretin-Based Drugs Sales by Application (2017-2022) & (K Units)
  • Table 86. Latin America Incretin-Based Drugs Sales by Application (2023-2028) & (K Units)
  • Table 87. Latin America Incretin-Based Drugs Revenue by Application (2017-2022) & (US$ Million)
  • Table 88. Latin America Incretin-Based Drugs Revenue by Application (2023-2028) & (US$ Million)
  • Table 89. Latin America Incretin-Based Drugs Sales by Country (2017-2022) & (K Units)
  • Table 90. Latin America Incretin-Based Drugs Sales by Country (2023-2028) & (K Units)
  • Table 91. Latin America Incretin-Based Drugs Revenue by Country (2017-2022) & (US$ Million)
  • Table 92. Latin America Incretin-Based Drugs Revenue by Country (2023-2028) & (US$ Million)
  • Table 93. Middle East and Africa Incretin-Based Drugs Sales by Type (2017-2022) & (K Units)
  • Table 94. Middle East and Africa Incretin-Based Drugs Sales by Type (2023-2028) & (K Units)
  • Table 95. Middle East and Africa Incretin-Based Drugs Revenue by Type (2017-2022) & (US$ Million)
  • Table 96. Middle East and Africa Incretin-Based Drugs Revenue by Type (2023-2028) & (US$ Million)
  • Table 97. Middle East and Africa Incretin-Based Drugs Sales by Application (2017-2022) & (K Units)
  • Table 98. Middle East and Africa Incretin-Based Drugs Sales by Application (2023-2028) & (K Units)
  • Table 99. Middle East and Africa Incretin-Based Drugs Revenue by Application (2017-2022) & (US$ Million)
  • Table 100. Middle East and Africa Incretin-Based Drugs Revenue by Application (2023-2028) & (US$ Million)
  • Table 101. Middle East and Africa Incretin-Based Drugs Sales by Country (2017-2022) & (K Units)
  • Table 102. Middle East and Africa Incretin-Based Drugs Sales by Country (2023-2028) & (K Units)
  • Table 103. Middle East and Africa Incretin-Based Drugs Revenue by Country (2017-2022) & (US$ Million)
  • Table 104. Middle East and Africa Incretin-Based Drugs Revenue by Country (2023-2028) & (US$ Million)
  • Table 105. GlaxoSmithKline Corporation Information
  • Table 106. GlaxoSmithKline Description and Major Businesses
  • Table 107. GlaxoSmithKline Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 108. GlaxoSmithKline Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 109. GlaxoSmithKline Recent Developments
  • Table 110. Johnson & Johnson Corporation Information
  • Table 111. Johnson & Johnson Description and Major Businesses
  • Table 112. Johnson & Johnson Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 113. Johnson & Johnson Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 114. Johnson & Johnson Recent Developments
  • Table 115. Merck & Co Corporation Information
  • Table 116. Merck & Co Description and Major Businesses
  • Table 117. Merck & Co Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 118. Merck & Co Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 119. Merck & Co Recent Developments
  • Table 120. AstraZeneca Corporation Information
  • Table 121. AstraZeneca Description and Major Businesses
  • Table 122. AstraZeneca Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 123. AstraZeneca Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 124. AstraZeneca Recent Developments
  • Table 125. Novartis Corporation Information
  • Table 126. Novartis Description and Major Businesses
  • Table 127. Novartis Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 128. Novartis Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 129. Novartis Recent Developments
  • Table 130. Eli Lilly and Company Corporation Information
  • Table 131. Eli Lilly and Company Description and Major Businesses
  • Table 132. Eli Lilly and Company Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 133. Eli Lilly and Company Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 134. Eli Lilly and Company Recent Developments
  • Table 135. Boehringer Ingelheim Corporation Information
  • Table 136. Boehringer Ingelheim Description and Major Businesses
  • Table 137. Boehringer Ingelheim Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 138. Boehringer Ingelheim Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 139. Boehringer Ingelheim Recent Developments
  • Table 140. Takeda Pharmaceutical Company Corporation Information
  • Table 141. Takeda Pharmaceutical Company Description and Major Businesses
  • Table 142. Takeda Pharmaceutical Company Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 143. Takeda Pharmaceutical Company Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 144. Takeda Pharmaceutical Company Recent Developments
  • Table 145. Sanofi Corporation Information
  • Table 146. Sanofi Description and Major Businesses
  • Table 147. Sanofi Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 148. Sanofi Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 149. Sanofi Recent Developments
  • Table 150. Key Raw Materials Lists
  • Table 151. Raw Materials Key Suppliers Lists
  • Table 152. Incretin-Based Drugs Distributors List
  • Table 153. Incretin-Based Drugs Customers List
  • Table 154. Incretin-Based Drugs Market Trends
  • Table 155. Incretin-Based Drugs Market Drivers
  • Table 156. Incretin-Based Drugs Market Challenges
  • Table 157. Incretin-Based Drugs Market Restraints
  • Table 158. Research Programs/Design for This Report
  • Table 159. Key Data Information from Secondary Sources
  • Table 160. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Incretin-Based Drugs Product Picture
  • Figure 3. Global Incretin-Based Drugs Market Share by Type in 2021 & 2028
  • Figure 3. Glucagon-like peptide-1 receptor (GLP-1) agonists Product Picture
  • Figure 4. Dipeptidyl Peptidase-4 (DPP-4) inhibitors Product Picture
  • Figure 5. Global Incretin-Based Drugs Market Share by Application in 2021 & 2028
  • Figure 6. Oral Drugs
  • Figure 7. Injectable Drugs
  • Figure 8. Incretin-Based Drugs Report Years Considered
  • Figure 9. Global Incretin-Based Drugs Sales 2017-2028 (K Units)
  • Figure 10. Global Incretin-Based Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 11. Global Incretin-Based Drugs Revenue 2017-2028 (US$ Million)
  • Figure 12. Global Incretin-Based Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
  • Figure 13. Global Incretin-Based Drugs Sales Market Share by Region (2017-2022)
  • Figure 14. Global Incretin-Based Drugs Sales Market Share by Region (2023-2028)
  • Figure 15. North America Incretin-Based Drugs Sales YoY (2017-2028) & (K Units)
  • Figure 16. North America Incretin-Based Drugs Revenue YoY (2017-2028) & (US$ Million)
  • Figure 17. Europe Incretin-Based Drugs Sales YoY (2017-2028) & (K Units)
  • Figure 18. Europe Incretin-Based Drugs Revenue YoY (2017-2028) & (US$ Million)
  • Figure 19. Asia-Pacific Incretin-Based Drugs Sales YoY (2017-2028) & (K Units)
  • Figure 20. Asia-Pacific Incretin-Based Drugs Revenue YoY (2017-2028) & (US$ Million)
  • Figure 21. Latin America Incretin-Based Drugs Sales YoY (2017-2028) & (K Units)
  • Figure 22. Latin America Incretin-Based Drugs Revenue YoY (2017-2028) & (US$ Million)
  • Figure 23. Middle East & Africa Incretin-Based Drugs Sales YoY (2017-2028) & (K Units)
  • Figure 24. Middle East & Africa Incretin-Based Drugs Revenue YoY (2017-2028) & (US$ Million)
  • Figure 25. The Incretin-Based Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
  • Figure 26. The Top 5 and 10 Largest Manufacturers of Incretin-Based Drugs in the World: Market Share by Incretin-Based Drugs Revenue in 2021
  • Figure 27. Global Incretin-Based Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
  • Figure 28. Global Incretin-Based Drugs Sales Market Share by Type (2017-2028)
  • Figure 29. Global Incretin-Based Drugs Revenue Market Share by Type (2017-2028)
  • Figure 30. Global Incretin-Based Drugs Sales Market Share by Application (2017-2028)
  • Figure 31. Global Incretin-Based Drugs Revenue Market Share by Application (2017-2028)
  • Figure 32. North America Incretin-Based Drugs Sales Market Share by Type (2017-2028)
  • Figure 33. North America Incretin-Based Drugs Revenue Market Share by Type (2017-2028)
  • Figure 34. North America Incretin-Based Drugs Sales Market Share by Application (2017-2028)
  • Figure 35. North America Incretin-Based Drugs Revenue Market Share by Application (2017-2028)
  • Figure 36. North America Incretin-Based Drugs Sales Share by Country (2017-2028)
  • Figure 37. North America Incretin-Based Drugs Revenue Share by Country (2017-2028)
  • Figure 38. U.S. Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 39. Canada Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 40. Europe Incretin-Based Drugs Sales Market Share by Type (2017-2028)
  • Figure 41. Europe Incretin-Based Drugs Revenue Market Share by Type (2017-2028)
  • Figure 42. Europe Incretin-Based Drugs Sales Market Share by Application (2017-2028)
  • Figure 43. Europe Incretin-Based Drugs Revenue Market Share by Application (2017-2028)
  • Figure 44. Europe Incretin-Based Drugs Sales Share by Country (2017-2028)
  • Figure 45. Europe Incretin-Based Drugs Revenue Share by Country (2017-2028)
  • Figure 46. Germany Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 47. France Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 48. U.K. Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 49. Italy Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 50. Russia Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 51. Asia Pacific Incretin-Based Drugs Sales Market Share by Type (2017-2028)
  • Figure 52. Asia Pacific Incretin-Based Drugs Revenue Market Share by Type (2017-2028)
  • Figure 53. Asia Pacific Incretin-Based Drugs Sales Market Share by Application (2017-2028)
  • Figure 54. Asia Pacific Incretin-Based Drugs Revenue Market Share by Application (2017-2028)
  • Figure 55. Asia Pacific Incretin-Based Drugs Sales Share by Region (2017-2028)
  • Figure 56. Asia Pacific Incretin-Based Drugs Revenue Share by Region (2017-2028)
  • Figure 57. China Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 58. Japan Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 59. South Korea Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 60. India Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 61. Australia Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 62. Taiwan Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 63. Indonesia Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 64. Thailand Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 65. Malaysia Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 66. Philippines Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 67. Latin America Incretin-Based Drugs Sales Market Share by Type (2017-2028)
  • Figure 68. Latin America Incretin-Based Drugs Revenue Market Share by Type (2017-2028)
  • Figure 69. Latin America Incretin-Based Drugs Sales Market Share by Application (2017-2028)
  • Figure 70. Latin America Incretin-Based Drugs Revenue Market Share by Application (2017-2028)
  • Figure 71. Latin America Incretin-Based Drugs Sales Share by Country (2017-2028)
  • Figure 72. Latin America Incretin-Based Drugs Revenue Share by Country (2017-2028)
  • Figure 73. Mexico Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 74. Brazil Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 75. Argentina Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 76. Middle East and Africa Incretin-Based Drugs Sales Market Share by Type (2017-2028)
  • Figure 77. Middle East and Africa Incretin-Based Drugs Revenue Market Share by Type (2017-2028)
  • Figure 78. Middle East and Africa Incretin-Based Drugs Sales Market Share by Application (2017-2028)
  • Figure 79. Middle East and Africa Incretin-Based Drugs Revenue Market Share by Application (2017-2028)
  • Figure 80. Middle East and Africa Incretin-Based Drugs Sales Share by Country (2017-2028)
  • Figure 81. Middle East and Africa Incretin-Based Drugs Revenue Share by Country (2017-2028)
  • Figure 82. Turkey Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 83. Saudi Arabia Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 84. UAE Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 85. Incretin-Based Drugs Value Chain
  • Figure 86. Incretin-Based Drugs Production Process
  • Figure 87. Channels of Distribution
  • Figure 88. Distributors Profiles
  • Figure 89. Bottom-up and Top-down Approaches for This Report
  • Figure 90. Data Triangulation
  • Figure 91. Key Executives Interviewed
目次

This research report focuses on the Incretin-Based Drugs Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Incretin-Based Drugs Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Incretin-Based Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Glucagon-like peptide-1 receptor (GLP-1) agonists
    • 1.2.3 Dipeptidyl Peptidase-4 (DPP-4) inhibitors
  • 1.3 Market by Application
    • 1.3.1 Global Incretin-Based Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Oral Drugs
    • 1.3.3 Injectable Drugs
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Incretin-Based Drugs Sales Estimates and Forecasts 2017-2028
  • 2.2 Global Incretin-Based Drugs Revenue Estimates and Forecasts 2017-2028
  • 2.3 Global Incretin-Based Drugs Revenue by Region: 2017 VS 2021 VS 2028
  • 2.4 Global Incretin-Based Drugs Sales by Region
    • 2.4.1 Global Incretin-Based Drugs Sales by Region (2017-2022)
    • 2.4.2 Global Sales Incretin-Based Drugs by Region (2023-2028)
  • 2.5 Global Incretin-Based Drugs Revenue by Region
    • 2.5.1 Global Incretin-Based Drugs Revenue by Region (2017-2022)
    • 2.5.2 Global Incretin-Based Drugs Revenue by Region (2023-2028)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Incretin-Based Drugs Sales by Manufacturers
    • 3.1.1 Global Top Incretin-Based Drugs Manufacturers by Sales (2017-2022)
    • 3.1.2 Global Incretin-Based Drugs Sales Market Share by Manufacturers (2017-2022)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Incretin-Based Drugs in 2021
  • 3.2 Global Incretin-Based Drugs Revenue by Manufacturers
    • 3.2.1 Global Incretin-Based Drugs Revenue by Manufacturers (2017-2022)
    • 3.2.2 Global Incretin-Based Drugs Revenue Market Share by Manufacturers (2017-2022)
    • 3.2.3 Global Top 10 and Top 5 Companies by Incretin-Based Drugs Revenue in 2021
  • 3.3 Global Incretin-Based Drugs Sales Price by Manufacturers (2017-2022)
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Incretin-Based Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Incretin-Based Drugs Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Incretin-Based Drugs Sales by Type
    • 4.1.1 Global Incretin-Based Drugs Historical Sales by Type (2017-2022)
    • 4.1.2 Global Incretin-Based Drugs Forecasted Sales by Type (2023-2028)
    • 4.1.3 Global Incretin-Based Drugs Sales Market Share by Type (2017-2028)
  • 4.2 Global Incretin-Based Drugs Revenue by Type
    • 4.2.1 Global Incretin-Based Drugs Historical Revenue by Type (2017-2022)
    • 4.2.2 Global Incretin-Based Drugs Forecasted Revenue by Type (2023-2028)
    • 4.2.3 Global Incretin-Based Drugs Revenue Market Share by Type (2017-2028)
  • 4.3 Global Incretin-Based Drugs Price by Type
    • 4.3.1 Global Incretin-Based Drugs Price by Type (2017-2022)
    • 4.3.2 Global Incretin-Based Drugs Price Forecast by Type (2023-2028)

5 Market Size by Application

  • 5.1 Global Incretin-Based Drugs Sales by Application
    • 5.1.1 Global Incretin-Based Drugs Historical Sales by Application (2017-2022)
    • 5.1.2 Global Incretin-Based Drugs Forecasted Sales by Application (2023-2028)
    • 5.1.3 Global Incretin-Based Drugs Sales Market Share by Application (2017-2028)
  • 5.2 Global Incretin-Based Drugs Revenue by Application
    • 5.2.1 Global Incretin-Based Drugs Historical Revenue by Application (2017-2022)
    • 5.2.2 Global Incretin-Based Drugs Forecasted Revenue by Application (2023-2028)
    • 5.2.3 Global Incretin-Based Drugs Revenue Market Share by Application (2017-2028)
  • 5.3 Global Incretin-Based Drugs Price by Application
    • 5.3.1 Global Incretin-Based Drugs Price by Application (2017-2022)
    • 5.3.2 Global Incretin-Based Drugs Price Forecast by Application (2023-2028)

6 North America

  • 6.1 North America Incretin-Based Drugs Market Size by Type
    • 6.1.1 North America Incretin-Based Drugs Sales by Type (2017-2028)
    • 6.1.2 North America Incretin-Based Drugs Revenue by Type (2017-2028)
  • 6.2 North America Incretin-Based Drugs Market Size by Application
    • 6.2.1 North America Incretin-Based Drugs Sales by Application (2017-2028)
    • 6.2.2 North America Incretin-Based Drugs Revenue by Application (2017-2028)
  • 6.3 North America Incretin-Based Drugs Market Size by Country
    • 6.3.1 North America Incretin-Based Drugs Sales by Country (2017-2028)
    • 6.3.2 North America Incretin-Based Drugs Revenue by Country (2017-2028)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Incretin-Based Drugs Market Size by Type
    • 7.1.1 Europe Incretin-Based Drugs Sales by Type (2017-2028)
    • 7.1.2 Europe Incretin-Based Drugs Revenue by Type (2017-2028)
  • 7.2 Europe Incretin-Based Drugs Market Size by Application
    • 7.2.1 Europe Incretin-Based Drugs Sales by Application (2017-2028)
    • 7.2.2 Europe Incretin-Based Drugs Revenue by Application (2017-2028)
  • 7.3 Europe Incretin-Based Drugs Market Size by Country
    • 7.3.1 Europe Incretin-Based Drugs Sales by Country (2017-2028)
    • 7.3.2 Europe Incretin-Based Drugs Revenue by Country (2017-2028)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Incretin-Based Drugs Market Size by Type
    • 8.1.1 Asia Pacific Incretin-Based Drugs Sales by Type (2017-2028)
    • 8.1.2 Asia Pacific Incretin-Based Drugs Revenue by Type (2017-2028)
  • 8.2 Asia Pacific Incretin-Based Drugs Market Size by Application
    • 8.2.1 Asia Pacific Incretin-Based Drugs Sales by Application (2017-2028)
    • 8.2.2 Asia Pacific Incretin-Based Drugs Revenue by Application (2017-2028)
  • 8.3 Asia Pacific Incretin-Based Drugs Market Size by Region
    • 8.3.1 Asia Pacific Incretin-Based Drugs Sales by Region (2017-2028)
    • 8.3.2 Asia Pacific Incretin-Based Drugs Revenue by Region (2017-2028)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America Incretin-Based Drugs Market Size by Type
    • 9.1.1 Latin America Incretin-Based Drugs Sales by Type (2017-2028)
    • 9.1.2 Latin America Incretin-Based Drugs Revenue by Type (2017-2028)
  • 9.2 Latin America Incretin-Based Drugs Market Size by Application
    • 9.2.1 Latin America Incretin-Based Drugs Sales by Application (2017-2028)
    • 9.2.2 Latin America Incretin-Based Drugs Revenue by Application (2017-2028)
  • 9.3 Latin America Incretin-Based Drugs Market Size by Country
    • 9.3.1 Latin America Incretin-Based Drugs Sales by Country (2017-2028)
    • 9.3.2 Latin America Incretin-Based Drugs Revenue by Country (2017-2028)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

10 Middle East and Africa

  • 10.1 Middle East and Africa Incretin-Based Drugs Market Size by Type
    • 10.1.1 Middle East and Africa Incretin-Based Drugs Sales by Type (2017-2028)
    • 10.1.2 Middle East and Africa Incretin-Based Drugs Revenue by Type (2017-2028)
  • 10.2 Middle East and Africa Incretin-Based Drugs Market Size by Application
    • 10.2.1 Middle East and Africa Incretin-Based Drugs Sales by Application (2017-2028)
    • 10.2.2 Middle East and Africa Incretin-Based Drugs Revenue by Application (2017-2028)
  • 10.3 Middle East and Africa Incretin-Based Drugs Market Size by Country
    • 10.3.1 Middle East and Africa Incretin-Based Drugs Sales by Country (2017-2028)
    • 10.3.2 Middle East and Africa Incretin-Based Drugs Revenue by Country (2017-2028)
    • 10.3.3 Turkey
    • 10.3.4 Saudi Arabia

11 Company Profiles

  • 11.1 GlaxoSmithKline
    • 11.1.1 GlaxoSmithKline Corporation Information
    • 11.1.2 GlaxoSmithKline Overview
    • 11.1.3 GlaxoSmithKline Incretin-Based Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.1.4 GlaxoSmithKline Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 GlaxoSmithKline Recent Developments
  • 11.2 Johnson & Johnson
    • 11.2.1 Johnson & Johnson Corporation Information
    • 11.2.2 Johnson & Johnson Overview
    • 11.2.3 Johnson & Johnson Incretin-Based Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.2.4 Johnson & Johnson Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Johnson & Johnson Recent Developments
  • 11.3 Merck & Co
    • 11.3.1 Merck & Co Corporation Information
    • 11.3.2 Merck & Co Overview
    • 11.3.3 Merck & Co Incretin-Based Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.3.4 Merck & Co Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Merck & Co Recent Developments
  • 11.4 AstraZeneca
    • 11.4.1 AstraZeneca Corporation Information
    • 11.4.2 AstraZeneca Overview
    • 11.4.3 AstraZeneca Incretin-Based Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.4.4 AstraZeneca Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 AstraZeneca Recent Developments
  • 11.5 Novartis
    • 11.5.1 Novartis Corporation Information
    • 11.5.2 Novartis Overview
    • 11.5.3 Novartis Incretin-Based Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.5.4 Novartis Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Novartis Recent Developments
  • 11.6 Eli Lilly and Company
    • 11.6.1 Eli Lilly and Company Corporation Information
    • 11.6.2 Eli Lilly and Company Overview
    • 11.6.3 Eli Lilly and Company Incretin-Based Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.6.4 Eli Lilly and Company Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Eli Lilly and Company Recent Developments
  • 11.7 Boehringer Ingelheim
    • 11.7.1 Boehringer Ingelheim Corporation Information
    • 11.7.2 Boehringer Ingelheim Overview
    • 11.7.3 Boehringer Ingelheim Incretin-Based Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.7.4 Boehringer Ingelheim Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Boehringer Ingelheim Recent Developments
  • 11.8 Takeda Pharmaceutical Company
    • 11.8.1 Takeda Pharmaceutical Company Corporation Information
    • 11.8.2 Takeda Pharmaceutical Company Overview
    • 11.8.3 Takeda Pharmaceutical Company Incretin-Based Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.8.4 Takeda Pharmaceutical Company Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 Takeda Pharmaceutical Company Recent Developments
  • 11.9 Sanofi
    • 11.9.1 Sanofi Corporation Information
    • 11.9.2 Sanofi Overview
    • 11.9.3 Sanofi Incretin-Based Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.9.4 Sanofi Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 Sanofi Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Incretin-Based Drugs Industry Chain Analysis
  • 12.2 Incretin-Based Drugs Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Incretin-Based Drugs Production Mode & Process
  • 12.4 Incretin-Based Drugs Sales and Marketing
    • 12.4.1 Incretin-Based Drugs Sales Channels
    • 12.4.2 Incretin-Based Drugs Distributors
  • 12.5 Incretin-Based Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Incretin-Based Drugs Industry Trends
  • 13.2 Incretin-Based Drugs Market Drivers
  • 13.3 Incretin-Based Drugs Market Challenges
  • 13.4 Incretin-Based Drugs Market Restraints

14 Key Findings in The Global Incretin-Based Drugs Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer